Clinical Trial Update: Zoledronic Acid in the Management of Patients With Asymptomatic/Early Stage Multiple Myeloma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating zoledronic acid for asymptomatic/early-stage multiple myeloma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Hoosier Cancer Research Network | Conditions: Multiple Myeloma | Phase 2 | Status: TERMINATED